US pharmaceutical distributor McKesson on Thursday announced the purchase of German rival Celesio in a deal valued at more than $8 billion.
US pharmaceutical distributor McKesson on Thursday announced the purchase of German rival Celesio in a deal valued at more than $8 billion
The combined company "will be one of the largest pharmaceutical wholesalers and providers of logistics and services in the healthcare sector worldwide," the German firm said in a statement.
The total transaction, including McKesson's takeover of Celesio's outstanding debt is valued at approximately $8.3 billion (6.3 billion euros, the statement added.
Both firms will keep their own separate brands.
The combined firm is expected to have annual revenue of more than $150 billion, employing some 81,500 people in 20 countries worldwide.
Earlier in the month, shares in McKesson rose sharply after the Wall Street Journal reported news of the buy-out.
Latest stories in this category:
- Swann catch ensures honours even in 2nd Ashes Test
- Japan launches $53.8 bn stimulus package
- FIFA readies for World Cup draw, puts delays aside
- US woman is star of 'Arabs Got Talent' TV show
- 'Fast and Furious' star died of impact, fire
- 'At least 20 dead' as Yemen defence complex stormed
- N. Korea prison camp expands, guards use rape and torture: report
- Ukraine hosts top diplomats as pressure grows on president